| Authors: |
Hartley AE; Human Genetics Centre of Excellence, Novo Nordisk Research Centre Oxford, UK. Electronic address: aphy@novonordisk.com., Sukhavasi K; Clinical Gene Networks AB, Stockholm, Sweden; Department of Cardiac Surgery and The Heart Clinic, Tartu University Hospital and Department of Cardiology, Institute of Clinical Medicine, Tartu University, Tartu, Estonia., Hu S; Human Genetics Centre of Excellence, Novo Nordisk Research Centre Oxford, UK., Traylor M; Human Genetics Centre of Excellence, Novo Nordisk Research Centre Oxford, UK., Gonzalez-Ramirez M; Human Genetics Centre of Excellence, Novo Nordisk Research Centre Oxford, UK., Hanghøj KE; Novo Nordisk A/S, Søborg, Denmark., Talukdar H; Clinical Gene Networks AB, Stockholm, Sweden; Department of Medicine, Karolinska Institutet, Karolinska Universitetssjukhuset, Huddinge, Sweden., Ruusalepp A; Clinical Gene Networks AB, Stockholm, Sweden; Department of Cardiac Surgery and The Heart Clinic, Tartu University Hospital and Department of Cardiology, Institute of Clinical Medicine, Tartu University, Tartu, Estonia., Björkegren E; Clinical Gene Networks AB, Stockholm, Sweden., Björkegren JL; Clinical Gene Networks AB, Stockholm, Sweden; Department of Medicine, Karolinska Institutet, Karolinska Universitetssjukhuset, Huddinge, Sweden., Howson JM; Chief Scientific Advisor Office, Novo Nordisk A/S, Oxford, UK., Jamshidi Y; Human Genetics Centre of Excellence, Novo Nordisk Research Centre Oxford, UK. Electronic address: yljm@novonordisk.com. |
